Market Place
Sourcing Support
All News #Library
Biotech
Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal
07 Mar 2026 //
BIOSPACE
Day One Reports 2025 Results, Reaffirms 2026 Guidance
24 Feb 2026 //
GLOBENEWSWIRE
Day One Completes Acquisition Of Mersana Therapeutics
06 Jan 2026 //
GLOBENEWSWIRE
Day One Reveals 3-Year Follow-Up Data On OJEMDA In FIREFLY-1
24 Nov 2025 //
GLOBENEWSWIRE
Day One To Present OJEMDA Data At 2025 SNO Annual Meeting
10 Nov 2025 //
GLOBENEWSWIRE
Day One Unveils Q3 2025 Financials & Corporate Advancements
04 Nov 2025 //
GLOBENEWSWIRE
Day One to Report Q2 2025 Financial Results on August 5
22 Jul 2025 //
GLOBENEWSWIRE
Day One Reports Q1 2025 Financial Results and Progress
06 May 2025 //
GLOBENEWSWIRE
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
19 Jun 2024 //
FIERCE PHARMA
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval
23 Apr 2024 //
PRESS RELAESE
Day One`s Tovorafenib Gets FDA Approval For Pediatric pLGG
23 Apr 2024 //
GLOBENEWSWIRE
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
17 Nov 2023 //
GLOBENEWSWIRE
Day One Announces Updated FIREFLY-1 Data for Tovorafenib
11 Sep 2023 //
GLOBENEWSWIRE
Day One goes to the market for $150M as biotech kicks off NDA request
07 Jun 2023 //
ENDPTS
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101)
04 Jun 2023 //
GLOBENEWSWIRE
Day One Announces TovorafenibData and Abstracts to be Presented at ASCO
25 May 2023 //
GLOBENEWSWIRE
Day One Announces Data from Phase 2 FIREFLY-1 Trial for Tovorafenib
08 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.